Furthermore, a study conducted in 2016 confirmed the expression of SIRT1 in the femoral neck region of patients with osteoporosis (128), thereby validating specific activation of SIRT1 as a potential therapeutic target for treating this condition. The gene discussed is SIRT1; the disease is osteoporosis.